Past Agendas

2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004

The Twitter hashtag for the 2019 event is #CVFORUM19. Request an invite if you are interested in joining us for the 2019 conference.

2019 Agenda


Wednesday, May 8th

4:00pm - 6:00pm
Pre-event Session Hosted by STAT+ | 28 Atlantic: Private Dining Room
The New Biology of Healthy Aging: Can Killing Your Old Cells Keep You Young?
Nathaniel David, Co-founder and President, Unity Biotechnology
Interviewer: Matthew Herper, Senior Medicine Writer, STAT
This session is open to all participants but seating is limited so pre-registration is required.

Thursday, May 9th

8:00am – 4:45pm
Registration | Pavilion Reception

8:00am –9:30am
Networking Breakfast | Garden Terrace

9:30am –10:00am
Welcome & Participant introductions | Pavilion

10:00am –10:45am | Pavilion
Frontier Science
Speaker: Ed Boyden, PhD, Associate Professor of Media Arts and Sciences and Y. Eva Tan Professor in Neurotechnology, MIT Media Lab and the MIT McGovern Institute
Speaker: Natalie Artzi, PhD, Assistant Professor at the Department of Medicine, Division of Engineering in Medicine, Brigham and Women’s Hospital, Harvard Medical School
Moderator: Iya Khalil, PhD, Co-founder, GNS

10:45am –11:15am
Networking Break

11:15am –12:00pm | Pavilion
Marijuana: Miracle or Myth?

Speaker: Ryan Ansin, Co-founder, Revolutionary Farms
Speaker: Staci Gruber, PhD, Director, Marijuana Investigations for Neuroscientific Discovery (MIND) Program, McLean Hospital
Moderator: Gabor Garai, Partner, Foley & Lardner

12:00pm –1:30pm | Garden Terrace
Lunch & Lunch Conversations

12:00pm –1:30pm | 28 Atlantic: Private Dining Room
Lunch Discussion: The Critical Hires as Your Program Gets off the Ground: Chief Development Officer or Chief Medical Officer?

Speaker: Tom Hughes, PhD, CEO, Navitor Pharmaceuticals
Speaker: Julia Owens, PhD, President and CEO, Millendo Therapeutics
Moderator: Laurie Halloran, President & CEO, Halloran Consulting

1:30pm –2:15pm | Pavilion
New Dynamics in R&D and Business Development with Eli Lilly and Company and Novartis Institutes for Biomedical Research
Ricardo Dolmetsch, PhD, Global Head of Neuroscience, Novartis Institutes for Biomedical Research
Daniel Skovronsky, MD, PhD, SVP and Chief Scientific Officer, Eli Lilly and Company
Moderator: Reid Leonard, PhD, Chief Operating Officer, Werewolf Therapeutics

2:15pm –2:30pm
Networking Break

2:30pm –3:30pm | Pavilion 1
Breakout Session A: A Look at Three Startups in Stealth

Speaker: Adam Friedman, MD, PhD, Founder, President & CEO, Vivid Biosciences, LLC
Speaker: Baruch Harris, PhD, Chief Operating Officer, Metera Pharmaceuticals, Inc. 
Speaker: James Rosen, CEO, Artizan Biosciences
Moderator: Marian Nakada, PhD, VP of Venture Investments, JJDC

2:30pm –3:30pm | Pavilion 2
Breakout Session B: Partnerships: What Makes Them Successful from the Start

Speaker: Mike Cloonan, Chief Business Officer, Sage Therapeutics
Speaker: Liz Leveille, Associate Vice President and Head, Boston Innovation Hub, BD&L, Merck
Moderator: Anna Protopapas, President and CEO, Mersana Therapeutics

2:30pm –3:30pm | 28 Atlantic: Private Dining Room
Breakout Session C: CFIUS and Other VC Deal Dynamics at Play in 2019
Bart Dzikowski, Head of Transactions & Legal, Novartis Venture Fund
Mark Engel, CEO, Phagelux
Jamie Heywood, Co-Founder & Chief Research Officer, iCarbonX
Moderator: Steve Dickman, CEO, CBT Advisors

3:30pm –3:45pm
Networking Break

3:45pm –4:30pm | Pavilion
True Stories from the Road to IPO (and Afterwards)
Pablo Cagnoni, MD, CEO, Rubius Therapeutics
Speaker: Jason Gardner, PhD, CEO, Magenta Therapeutics
Moderator: Matthew Herper, Senior Writer, Medicine, and Editorial Director, Events, Stat

4:45pm –6:15pm | 28 Atlantic: Private Dining Room
Sign Up on-site required, limited space
Wine Tasting: Hosted by UBS

4:45pm –6:45pm | Sign Up on-site required, limited space in each
Bay Cruise | Golf Workshop |
 Chocolate Tasting & Truffle Making

7:00pm –9:30pm | Outer bar

FRIDAY, May 10th

8:00am – 3:00pm
Registration | Pavilion Reception

8:00am - 9:00am
Breakfast Discussion | 28 Atlantic: Private Dining Room

Balancing the Needs of the Board, Management, and Employees
Speaker: Rob Albarano, Managing Director, L.E.K. Consulting
Speaker: Sandra Glucksmann, CEO, Cedilla Therapeutics
Speaker: Jeff Jonker, CEO, Ambys Medicines

8:00am – 9:00am
Networking Breakfast | Garden Terrace

9:00am – 9:45am | Pavilion
Leadership Lessons
David Meeker, MD, CEO, KSQ Therapeutics
Speaker: John Maraganore, PhD, CEO, Alnylam Pharmaceuticals
Speaker: Kazumi Shiosaki, PhD, President and CEO, Twentyeight-Seven
Moderator: Anne Mostue, Reporter and Anchor, Bloomberg News Radio and Television

9:45am – 10:15am
Networking Break

10:15am – 11:00am | Pavilion
Healthcare: Are We Focusing on All the Wrong Things?
Sandro Galea, MD, MPH, DrPH, Dean and Robert A. Knox Professor, School of Public Health, Boston University
Moderator: Alison Taunton-Rigby, OBE, PhD, Director & Trustee, Healthcare, Life Sciences and Financial Services

11:00am – 11:30am
Networking Break

11:30am – 12:15pm | Pavilion
Digital Therapeutics: What's Possible?

Speaker: Eddie Martucci, PhD, Co-Founder and CEO, Akili Interactive Labs
Speaker: Corey McCann, MD, PhD, Founder and CEO, Pear Therapeutics Inc.
Speaker: Joris van Dam, PhD, Executive Director, Head of Digital Therapeutics, Novartis Institute for BioMedical Research (NIBR)
Moderator: Karen Bernstein, PhD, Co-Founder and Chairman, BioCentury Inc.

12:15pm – 1:30pm | Garden Terrace
Lunch & Lunch Conversations

1:30pm – 2:00pm | Pavilion
Inside Ipsen: A Look at the Company’s Strategy in North America
Ivana Magovcevic-Liebisch, PhD, JD, Executive VP & Chief Business Officer, Ipsen S.A
Matthew Herper, Senior Writer, Medicine, and Editorial Director, Events, STAT

2:00pm – 2:15pm
Networking Break

2:15pm – 3:15pm | 28 Atlantic: Private Dining Room
Tough Tech: Building Companies Around Risky Technology

Speaker: Paulo Garcia, PhD, Co-Founder and CEO, Kytopen Corp.
Nabiha Saklayen, PhD, CEO and Co-Founder, Cellino
Moderator: Ann DeWitt, PhD, General Partner, The Engine